Patent · US Active

Synthetic single domain antibody

US10017559B2 · kind B2 · utility

0Cited by

0References

2Claims

0Family size

Assignees

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
INSTITUT CURIE · FR
UNIVERSITE PAUL SABATIER—TOULOUSE III · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR

Inventors

Aurellen Olichon · Toulouse, FR
Sandrine Moutel · Paris, FR
Franck Perez · Paris, FR

Key dates

Filing date	Nov 4, 2014
Grant date	Jul 10, 2018
Priority date	—
Expiry date	Apr 17, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC40B50/06
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to the identification of a highly stable single domain antibody scaffold (hs2d Ab) and its use in generating synthetic single domain antibody library (hs2d Ab-L1). The invention also relates to antigen-binding proteins comprising said stable single domain antibody scaffold and their uses, in particular as therapeutics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.